LONDON--(BUSINESS WIRE)--Technavio’s global implantable cardioverter defibrillators (ICD) market research report forecasts the market to grow at a CAGR of almost 2% during the forecast period. The ...

Medically reviewed by Jeffrey S. Lander, MD Key Takeaways Taking medications like beta-blockers, ACE inhibitors, and statins ...

The indications for ICD implantation continue to expand; however, these devices are associated with complications related to the implantation procedure itself and morbidity caused by the normal and ...

Some young adults have inherited heart conditions that require them to receive an implantable cardioverter defibrillator, or ICD. For years, they were told they could not engage in sports more ...

Boston Scientific has begun a clinical trial of its first modular cardiac rhythm implant system. It consists of a leadless pacemaker and an implantable cardioverter defibrillator—two separate devices ...

The risk associated with implantation of the implantable cardioverter-defibrillator (ICD) is often focused on the immediate complications of the procedure. The long-term risk of having an ICD, ...

Background: Although more than 150,000 implantable cardioverter defibrillators (ICDs) are implanted yearly worldwide, only few studies systematically examined complications of ICD therapy in large ...

1 in 5 with implantable cardioverter-defibrillator don't meet criteria for use. Jan. 4, 2011— -- One in five patients who receive the heart-shocking, life-saving devices known as implantable ...

A standard test of the implantable cardioverter defibrillator (ICD) is linked to significant thought-processing problems that improve for most patients within a year after the device is inserted, ...